Porcine circovirus type 2 (PCV2) is a single-stranded circular DNA virus associated with Postweaning multisystemic wasting syndrome (PMWS), which is considered to be an important infectious swine viral disease. PCV2 capsid protein encoded by ORF2 is a structural protein and expected as the high immunogenicity protein. In this study, we generated recombinant baculovirus containing ORF2 of PCV2 and analyzed the optimal conditions for the production of capsid protein in insect cell. Production and status of recombinant capsid protein in insect cell were confirmed by SDS-PAGE and Western blot analysis using His tag antibody and anti-PCV2 serum. The yield of recombinant capsid protein was high like as shown visible on SDS-PAGE. Optimal multiplicity of infection (MOI) and infection time of recombinant virus were determined as 5 MOI and 4 days, respectively. ORF2 is known to have Nlinked glycosylation site, but we couldn't detect the glycosylation of recombinant protein in insect cells.
Introduction
Postweaning multisystemic wasting syndrome (PMWS) is a viral disease which is characterized by progressive weight loss, respiratory and digestive disorders in postweaned pigs. Since PMWS was first identified in western Canada in 1991 Clark, 1997; Meehan et al., 1998) , PMWS has become an economically important and serious disease in the world (Allan and Ellis, 2000; Trundova and Celer, 2007) . Porcine circovirus type 2 (PCV2), a single-stranded circular DNA virus associated with PMWS of swine, has two major open reading frames, ORF1 and ORF2 (Nawagitgul et al., 2000) . ORF1 encodes a replicase protein essential for viral DNA replication. ORF2 encodes the 28kDa capsid protein, which is a unique structural protein of the virus. The capsid protein encoded by ORF2 has type-specific epitopes (Liu et al., 2001; Mahe et al., 2000) and is very immunogenic and associated with the induction of neutralizing antibodies (Pogranichnyy et al., 2000) . This strongly reacts with serum from PCV2-infected swine, and acts as major targets for the immune responses of the infected animals (Liu et al., 2004) . Thus, one approach to control PCV2 widespread was the use of the capsid protein of PCV2 as subunit vaccine (Fan et al., 2007) , and its potential capability is worth in diagnostic assays as well as vaccine development (Liu et al., 2008; Nawagitgul et al., 2002) .
The baculovirus expression vector system (BEVS) has long been used to produce and to confirm molecular characteristic of various heterologous genes for the various research and industrial purposes including development of vaccine (Choi et al., 1999; Maeda, 1994; Matsuo et al., 2006 , O'Reilly et al., 1992 . This system has unique features and many advantages that are cost reducible production, harmless to humans, efficient expression, proper post-translational modification, and correct conformation (Liu et al., 2008) .
In this study, we generated recombinant baculovirus to express PCV2 capsid protein and investigated optimal conditions for the efficient production of recombinant protein in insect cells. 
Materials and Methods
Cloning and generation of recombinant baculovirus Viral DNA was extracted from the PCV2 KSY-1 strain (GenBank: AF454546), and the full-length ORF2 of PCV2 was amplified by PCR using primer. Primer sequences were 5' AGATCTATGACGTATCCAAG-GAGG 3' and 5' CTCGAGTTAGTGGTGGTGGTGGTG-GTGGGGGTTAAGTGGG 3'. The forward primer contained the BglII site (under lined) before the start codon, and the reverse primer contained the 6x His and XhoI site (under lined) before and after the stop codon, respectively. The amplified ORF2 fragment was purified by using a gel extraction kit and was cloned into the T&A cloning vector (RBC bioscience). After obtaining a sufficient plasmid DNA, it was digested with BglII and XhoI. The purified 730bp fragment was appropriately ligated into the baculovirus transfer vector pBacPAK9 (Clontech, CA) using ligation kit (TaKaRa, Japan).
The Spodoptera frugiferda cell line (Sf21) was maintained with SFM (Gibco BRL, USA) and seeded into T-25 flask (SPL Co. Ltd., Korea). Transfection mixture containing bAcGOZA (Je et al., 2001 ) and recombinant transfer vector was mixed with Lipofectin (Invitrogen, USA) and placed in 27°C for 30min. Cells were transfected with transfection mixture drop by drop and placed at room temperature. After 4hrs of incubation, the medium was removed and replaced with 5ml fresh insect cell culture medium SFM. After 5 days, the supernatant was harvested. A standard plaque assay procedure was used to obtain viral plaques from dilutions of the media harvested from the co-transfections (O'Reilly et al., 1992) . The purified recombinant virus was propagated in Sf21 cells. The titer was expressed as plaque forming units (pfu) per milliliter according to standard method.
Protein expression
For the protein expression, Sf21 cells were seed at a concentration of 1.0 × 10 6 cells/well into 6 well tissue culture plate and infected with recombinant virus. After infection, the culture supernatant was harvested by centrifugation at 1,000 g for 5 min, washed with PBS and resuspended in lysis buffer (iNtRON, Korea). The resuspended cells were lysed by sonication and then mixed with protein sample buffer and boiled at 100 o C for 10 min. Prepared protein samples were electrophoresed on 12% SDS-PAGE gel, and separated proteins were stained with Coomassie brilliant blue and transferred onto a nitrocellulose membrane, respectively. Western blot hybridization was carried out as follows. Membrane was blocked with 5% skim milk, and reacted with anti-His mouse monoclonal antibody (abm Inc., CA) or anti-PCV2 serum, and HRP-linked anti mouse IgG (Cell signaling, USA) or antispecies antibody for secondary antibody. The blots were washed with 0.1% TBS-Tween buffer, and visualized using the ECL Western Blotting Detection System (Elpis Biotech, Daejeon, Korea).
Glycosylation analysis
Glycosylation of recombinant protein was determined whether it is glycoprotein or not using Gelcode Glycoprotein Staining Kit (Pierce biotechnology, USA). For linked site confirmation, the infected medium was replaced with fresh serum-free insect cell culture medium including 5 ug/ml tunicamycin or final concentration of 3 mM Benzyl-N-acetyl-α-D-galactosaminide (BAG). The harvested cells were immunoblotted by the methods previously described for protein analysis using SDS-PAGE and Western blot hybridization.
Results and Discussion
Generation of recombinant baculovirus ORF2 of PCV2 was successfully amplified from PCV2 KSY-1 strain and its sequence was confirmed. To generate the recombinant baculovirus, Sf21 cells were co-transfected with a mixture of bAcGOZA and pBacPAK9-PCV2ORF2 (Fig. 1) . Purified recombinant baculovirus was achieved by plaque assay method and its purity was confirmed by PCR and restriction enzyme analysis (data not shown). The recombinant virus was named as rAcPCV2ORF2 (Fig. 1) .
Expression of PCV2 capsid protein
To analyze the expression of the recombinant capsid protein, Sf21 cells were infected with rAcPCV2ORF2 at 1 MOI and harvested at 3 days post infection (p.i.). Expression of the recombinant protein was analyzed by SDS-PAGE and Western blot hybridization. The recombinant capsid protein at about 28kDa corresponding to the expected molecular size of capsid protein with 6x His-tag was observed clearly on SDS-PAGE and detected by Western blot hybridization analysis using 6x His-tag antibody (Fig. 2) . The recombinant protein expressed in the infected Sf21 cells was only observed in cell lysate supernatant (Fig. 2) . Although there is previous report about the formation of capsid particle when ORF2 is expressed in insect cells (Fan et al., 2007) , we could not detect recombinant protein in cell lysate pellet because of insufficient centrifugation speed. The recombinant capsid protein was also detected with anti-PCV2 serum (Fig. 2C) . This result indicates that recombinant capsid protein produced in insect cells has immunogenicity against PCV2. Above results showed that ORF2 could be expressed efficiently in insect cells and this may be used directly as the antigen for the vaccine.
Optimization of recombinant protein expression in Sf21 cells
To determine optimal titer and infection time for the production of recombinant protein the cells infected with rAcPCV2ORF2 were harvested daily until 7 days p.i. Expression of recombinant protein was first detected on day 2 and peaked on day 4 p.i. (Fig. 3A) . The longer infection time did not influence the process of recombinant protein production. After infection with frequently used MOI 1, 5 and 10 the recombinant protein yield was compared. As the result we determined 5 MOI as the optimal titer to infect cells because 5 and 10 MOI showed similar production of recombinant protein (Fig. 3B ).
Glycosylation analysis of recombinant protein
The glycosylation of recombinant protein was analyzed by glycoprotein staining method (Fig. 4A) and treatment of glycosylation inhibitors (Fig. 4B ) because ORF2 is known to have N-linked glycosylation site (Hamel et al., 1998) . However, we could not identify glycosylation of recombinant capsid protein with these methods. Although putative amino acid sequence of the ORF2 possessed at least one glycosylation site (Hamel et al., 1998) , there is no experimental report prove it until now. The glycosylation of recombinant glycoprotein in insect cells is not perfect compared to other vertebrate system but superior than other prokaryote system. Thus, the glycosylation of recombinant PCV2 capsid protein should be further analyzed.
We are currently investigating the enhanced production of recombinant PCV2 capsid protein which may be useful for the development of new, safe, effective and economical vaccines against PCV2.
